Skip to main content
Media Relations
Investor Relations
Home
Products
Microtiter Plate Assays
penKid
bio-ADM
Lightning
Science
Research Settings: Critical Conditions
Biomarkers for Critical Conditions
penKid: kidney function biomarker
bio-ADM: endothelial function biomarker
Pathophysiology
Acute Kidney Injury
Sepsis
Collaboration
Service Measurements
Network
Clinical Evaluation
Biomarker Out-Licensing
Company
About us
Team
Careers
Open Positions
News
Events
Investor Relations
Media Relations
Newsletter
(current)
Contact us
Resource Center
Downloads
Scientific Publications
Webinars
Practice-Oriented Management of Acute Dialysis in Cardiac Surgery Patients: Strategies and Challenges in Clinical Practice
Role of Proenkephalin in Assessing Recovery from AKI and AKI-D
The Implementation of a Novel Kidney Function Biomarker in Clinical Routine
Using Proenkephalin as a Novel Biomarker to Estimate GFR
Using bio-ADM and penKid for Optimization of AHF Management in Daily Clinical Practice
Point-of-care Diagnostics in the Emergency Department: Better Patient Management
Sepsis in the Emergency Department: Recognizing High-Risk Patients With the Biomarker Bioactive Adrenomedullin
Overcoming the Limitations of Acute Kidney Injury (AKI) Diagnostics in the Emergency Department: the Biomarker Proenkephalin for Early Recognition of AKI
Blog
Search
Order
Contact us
Newsletter
You are here:
Home
Company
Newsletter
